Developing Operational Definitions Related to Helicobacter pylori Eradication Therapy

Area of Science:

• Medical Informatics
• Gastroenterology
• Clinical Research Methodology

Background:

• Secondary databases lack standardized operational definitions, hindering Helicobacter pylori eradication studies.
• This study addresses the critical need for validated definitions in H. pylori eradication research.

Purpose of the Study:

• To develop and validate operational definitions for H. pylori eradication therapy.
• To improve the reliability of H. pylori eradication studies utilizing secondary data sources.

Main Methods:

• Operational definitions were derived from a national H. pylori eradication registry.
• Validation was performed using real-world hospital medical record data.
• Primary endpoint: sensitivity in identifying patients receiving H. pylori eradication therapy; Secondary endpoint: sensitivity and specificity for successful eradication.

Main Results:

• High sensitivity (99.7%-99.8%) was achieved in identifying patients undergoing first- and second-line H. pylori eradication therapy.
• Operational definitions for successful eradication demonstrated high sensitivity (97.6%-98.6%) and variable specificity (91.4% for first-line, 54.8% for second-line).
• Defined eradication regimens included specific combinations of proton pump inhibitors (PPIs) and antibiotics (amoxicillin, clarithromycin, metronidazole, tetracycline, levofloxacin, moxifloxacin, rifabutin).

Conclusions:

• Validated operational definitions for H. pylori eradication therapy have been successfully developed.
• These definitions are expected to facilitate more robust H. pylori eradication research using secondary databases.
• The definitions enhance the ability to accurately assess treatment outcomes in large-scale studies.